News

No	Subject	Date
1	2026/10/12 Horien Biotech Online Seminar：Chatting with you	2026-09-14
2	Horien Biotech’s Global Expansion Gains Renewed Attention: Three Class 4 Approvals from the Thai FDA and U.S. Patent Achievements Featured in International Media	2026-09-09
3	2026 Taiwan Asia-Pacific Dental Implant Society \| August 15-16 \|	2026-08-17
4	Biodegradable Ureteral Stent Receives US Patent	2026-08-06
5	#Horien Biotech x #Anliden \| Course support 8/2	2026-08-02
6	"Mnews" Horien Biotech Lists on the OTC Market Today; Certification Obtained in Thailand, Bio-inks Expand into Europe, Aiming for Overseas Growth	2026-07-17
7	"UDN.COM" Horien Biotech's stock price surged on its first day of trading, with intraday gains exceeding 10%.	2026-07-17
8	“Investment Weekly” Horien Biotech's stock price surged as much as 13% on its first day of trading on the over-the-counter market, with new products and export sales driving continued strong momentum for the second half of the year.	2026-07-17
9	"Liberty Times" Focus Stock: Horien Biochemical Technology: Shares Soar on First Day of Listing; Southeast Asian High-End Medical Devices Strategy Taking Shape	2026-07-17
10	“TechNews” Horien Biotech's stock price surged on its first day of trading on the OTC market! It has gained access to ASEAN's high-end medical device market.	2026-07-17
11	"USTV" Horien Biotech's stock price surged 7% after listing on the over-the-counter market! It has entered the high-end medical device market in Southeast Asia and obtained the highest-level Class 4 market approval in Thailand.	2026-07-17
12	“Commercial Times” Horien's listing on the over-the-counter market marks a 209% year-on-year increase in June revenue; three medical device licenses in Thailand support its overseas expansion.	2026-07-16
13	"China Times" Biomedical stocks: Horien Biotech, a newcomer in the biotech industry, saw its membership increase by over 10%, and its international expansion is flourishing.	2026-07-16
14	"anue” Focus Stocks report: Horien Biotech defies market weakness, goes public today and is experiencing a honeymoon period with gains exceeding 10%.	2026-07-16
15	"UDN.COM" Horien Biotech's listing on the OTC market and its expansion into ASEAN and Europe bring good news; a multi-billion dollar blue ocean medical device market is poised for growth.	2026-07-16